Chronic non-cancer pain and the long-term efficacy and safety of opioids: Some blind men and an elephant?

Scandinavian Journal of Pain

Volumn 3, Issue 1, 2012, Pages 5-13

  Watson, C Peter N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic non cancer pain; Long term safety and efficacy; Opioids

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CARBAMAZEPINE; DOCUSATE SODIUM; FENTANYL; FLUNARIZINE; GABAPENTIN; METHYLPREDNISOLONE; MORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PAROXETINE; PENTAZOCINE; PETHIDINE; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ABDOMINAL PAIN; ADULT; ALLODYNIA; ANALGESIA; ARTHRALGIA; ARTICLE; BRIEF PAIN INVENTORY INTERFERENCE SCALE; CHRONIC NON CANCER PAIN; CHRONIC PAIN; CLINICAL ARTICLE; CONSTIPATION; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; DRUG TREATMENT FAILURE; DRUG USE; FEMALE; FOLLOW UP; GLOSSOPHARYNGEAL NEURALGIA; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMMUNE STATUS; KNEE PAIN; LEG PAIN; MALE; MIGRAINE; MOOD; NEUROPATHIC PAIN; NUMERICAL RATING SCALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN DISABILITY INDEX; PATIENT SATISFACTION; PHANTOM PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL FUNCTION; SHORT FORM HEALTH SURVEY 12 VERSION 2; UNSPECIFIED SIDE EFFECT;

EID: 84855821603     PISSN: 18778860     EISSN: 18778879     Source Type: Journal    
DOI: 10.1016/j.sjpain.2011.11.001     Document Type: Article

References (49)

1. Ballantyne J. Pain medicine: repairing a fractured dream. Anesthesiology 2011, 114:243-246.
2. Sjogren P. Epidemiology of pain and critical issues in opioid use. Pain 2011, 152:1219-1220.
3. Eriksen J., Jensen M.K., Sjogren P., Ekholm O., Rasmussen N.K. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003, 106:221-228.
4. Sjogren P., Ekholm O., Peuckmann V., Groenbaek M. Epidemiology of chronic pain in Denmark: an update. Eur J Pain 2009, 13:287-292.
5. Toblin R.L., Mack K.A., Perveen G., Paulozzi L.J. A population based survey of chronic pain and its treatment with prescription drugs. Pain 2011, 1152:1249-1255.
6. Gureje O., Von Korff M., Simon G.E., Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA 1998, 280:147-151.
7. Joransen D.E. Improving availability of opioid pain medications; testing the principle of balance in Latin America. J Palliat Med 2004, 7:105-114.
8. Claussen T.G., Eriksen J., Borgbjerg F.M. Legal opioid consumption in Denmark in 1981-1993. Eur J Clin Pharmacol 1995, 48:321-325.
9. Dhalla I.A., Mamdani M.M., Silviotti M.L.A., Kopp A., Qureshi O., Juurlink D.N. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009, 181:891-896.
10. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010, 363:1981-1985.
11. Gomes T., Juurlink D.N., Dhalla I.A., Mailis-Gagnon A., Paterson J.M., Mamdani M.M. Trends in opioid use and dosing among socio-economically disadvantaged patients. Arch Int Med 2011, 171:686-691.
12. Watson C.P.N., Babul N. Oxycodone relieves neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837-1841.
13. Harati Y., Gooch C., Swensen M., Edelman S., Greene D., Raskin P., Donofrio P., Cornblath D., Sachdeo R., Siu C., Kamin M. Double blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846.
14. Sindrup S.H., Andersen G., Madsen C., Smith T., Brosen R., Jensen T.S. Tramadol relieves pain and allodynia in polyneuropathy; a randomized, double-blind, controlled trial. Pain 1999, 83:85-90.
15. Rowbotham M.C., Twilling L., Davies P.S., Reisner L., Taylor K., Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003, 349:1223-1232.
16. Raja S.J., Haythornethwaite J.A., Papagallo M., Clark M.R., Travison T.G., Sabeen S., Royall R.M., Max M.B. Opioids versus antidepressants in postherpetic neuralgia; a placebo-controlled study. Pain 2002, 94:215-224.
17. Watson C.P.N., Moulin D., Watt-Watson J., Gordon A., Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003, 105:71-77.
18. Gimbel J.S., Richards P., Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003, 60:927-934.
19. Boureau F., Legallicier P., Kabir-Ahmadi M. Tramadol in postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003, 104:323-331.
20. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., Houlden R.L. Morphine, gabapentin or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
21. Jaffe J. Opiates: clinical aspects. Substance abuse. A comprehensive textbook 1992 p, 186-194. Williams and Wilkins, Baltimore. J.H. Lowinson, P. Ruiz, R.G. Millman (Eds.).
22. Sees K.L., Clark K.W. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage 1993, 8:257-264.
23. Savage S.R. Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996, 11:274-286.
24. Sacerdote P., Manfredi B., Manttegazza P., Panerai A.E. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol 1997, 121:834-840.
25. Sjogren P., Olsen A.K., Thomsen A.B. Impaired neuropsychological performance in chronic non-malignant pain patients receiving long-term oral therapy. J Pain Symptom Manage 2000, 19:100-108.
26. Mao J. Opioid-induced abnormal pain sensitivity; implications in clinical opioid therapy. Pain 2002, 100:213-217.
27. Rajogopal A., Vassilopoulou-Sellin R., PalmerJL, Kaur G., Brera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to morphine. Cancer 2004, 100:851-858.
28. Vallejo R., de Leon-Casasola O., Benyamin R. Opioid therapy and immunosuppression. A review. Am J Ther 2004, 11:354-365.
29. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. Narcotic analgesics in anesthesiology 1982, 199-208. Williams and Wilkins, Baltimore, MD. L.M. Kitahata, D. Collins (Eds.).
30. Portenoy R.K., Foley R.M. Chronic use of opioid analgesics in non-malignant pain. Report of 38 cases. Pain 1986, 25:171-186.
31. Tennant F.S., Robinson D., Sagherian A., Seecof R. Chronic opioid treatment of intractable non-malignant pain. Pain Manage 1988, 18-36.
32. Zenz M., Strumpf M., Tryba M. Long-term oral opioid therapy in patients with nonmalignant pain. J Pain Symptom Manage 1992, 7:69-77.
33. Watson C.P.N., Watt-Watson J., Chipman M.L. Chronic non-cancer pain and the long term utility of opioids. Pain Res Manage 2004, 9:19-24.
34. Watson C.P.N., Watt-Watson J.H., Chipman M.A. The long-term efficacy and safety of opioids: a survey of 84 selected patients with intractable chronic non-cancer pain. Pain Res Manage 2010, 15(4):213-218.
35. Becker N., Thomsen A.B., Olsen A.K., Sjogren P., Bech P., Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 2000, 73:393-400.
36. Jensen M.K., Thomsen A.B., Hojsted J. 10 year follow-up of chronic non-malignant pain patients; opioid use, health related quality of life and health care utilization. Eur J Pain 2006, 10:423-433.
37. Eriksen J., Sjogren P., Bruera E., Ekholm O., Rasmussen N.K. Critical issues in chronic non-cancer pain: an epidemiological study. Pain 2006, 125:172-179.
38. Daut I.E., Cleeland C.S., Flanery R.C. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983, 17:197-210.
39. Tait R.C., Chibnall J.T., Krause S. The Pain Disability Index; psychometric properties. Pain 1990, 40:171-182.
40. Chibnall J.T., Tait R.C. The Pain Disability Index: factor structure and normative data. Arch Phys Med Rehabil 1994, 75:1082-1086.
41. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
42. Ware J.E., Kosinski M., Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
43. Khoromi S., Cui L., Nackers L., Max M.B. Morphine versus nortriptyline and their combination in chronic lumbar root pain. Pain 2007, 130:66-75.
44. Chou R., Fanciullo G.J., Fine P.G., Adler A.M., Ballantyne J.C., Davies p, Donovan M.I., Fishbain D.A., Foley K.M., Fudin J., Gilson A.M., Kelter A., Mauskop A., O'Connor P.G., Passik S.D., Pasternak G.W., Portenoy R.K., Rich B.A., Roberts R.G., Todd K.H., Miaskowski C. Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain 2009, 10:113-130.
45. Butler S.F., Fernandez K., Benoit C. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain 2005, 9:345-352.
46. Webster L.R., Webster R.M. Predicting aberrant behaviour in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med 2005, 6:432-442.
47. Kieburtz K., Simpson D., Yiannoutsios C., Max Mb., Hall C.D., Ellis R.J., Marra C.M., McKendall R., Singer E., Dal Pan G.J., Clifford D.B., Tucker T., Cohen B. A randomized trial of amitriptyline and mexiletine in painful neuropathy in HIV infection. Neurology 1998, 51:1682-1688. the AIDs Clinical Trial Group 242 Protocol Team.
48. Mitchell S.W. Injuries of nerves and their consequences 1872, JB Lippincott & Co, p. 270.
49. Furlan A.D., Reardon R., Weppler C. Opioids for chronic non-cancer pain: a new Canadian practice guideline. CMAJ 2010, 182(9):923-930.